Please assess the completion status of the following clinical trial:

Trial Title: YF476 and Type I Gastric Carcinoids

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients known to have gastric carcinoids associated with chronic atrophic gastritis and hypergastrinaemia, and who attend the outpatient clinic of the investigator;~* Men, postmenopausal women, premenopausal women who have been sterilised by tubal ligation, hysterectomy or bilateral oophrectomy, or premenopausal women using reliable contraception: condom and spermicide or intrauterine device;~* Adults ≥ 18 years;~* Good general health; and~* Able to give fully-informed, written consent.~Exclusion Criteria:~* Women who are pregnant, lactating or using a steroid contraceptive;~* History of gastric surgery, apart from surgery for gastric carcinoids;~* Evidence of Zollinger-Ellison syndrome;~* Prolonged QTc interval (\>450 msec);~* Certain medicines and herbal remedies taken during the 7 days before visit 1;~* Previous treatment with somatostatin; or~* Participation in other clinical trials of unlicensed medicines within the previous 3 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- YF476 treatment (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).